Why the study?
Does rapid-sequence 31P-MRS detect differences in myocardial PCr/ATP ratios between cardiac patients and normal volunteers?
Does rapid-sequence 31P-MRS detect differences in myocardial PCr/ATP ratios between cardiac patients and normal volunteers?
Rapid-sequence 31P-MRS is a clinically feasible diagnostic tool that can detect significantly lower myocardial PCr/ATP ratios in patients with cardiac disease compared to normal volunteers.
No takes yet. Share an insight, caveat, or question.
Rapid 31P-MRS detects energetic differences in dysfunction; leaves open its diagnostic role pending prospective validation.
Chida et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: